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and high vitamin D levels (P< 0.001) are strongly associated
with SVR.
Conclusions: Low serum HDL and high vitamin D levels
are strongly associated with sustained viral response in
chronic HCV naïve genotype-1 patients.
PP-131 Screening of proteins binding to hepatitis C
virus NS4B protein from human pancreas
cDNA library
N. Ren*, X. Li. Beijing, China
Objective: To screen gene encoding of pancreatic proteins
from human pancreas cDNA library, which interact with
hepatitis C virus (HCV) NS4B protein.
Method: The human pancreas cDNA library was ampliﬁed,
puriﬁed and evaluated, and the puriﬁed library plasmids
were transformed into yeast strain Y187. The reconstructed
plasmid pGBKT7-NS4B was transformed into yeast strain
AHl09 and the positive colonies were screened on the
nutrient deﬁciency medium SD/-Trp. The transformed AHl09
mated with Y187 that contained the library plasmids via
the yeast two hybridization system3. The diploid yeast cells
were placed on nutrient deﬁciency medium SD/-Trp/-Leu/
-His/-Ade and SD/-Trp/-Leu/-His/-Ade containing X-a-gal for
selecting. The Blue yeast colony plasmid were extracted and
electrotransformed into E. coli DH5a. The plasmids in DH5a
were extracted, sequenced and blasted.
Results: The human pancreas cDNA library was constructed
successfully. The reconstructed bait plasmid (pGBKT7-HCV
NS4B) was transformed into yeast cells AHl09 successfully.
Seven proteins interacting with HCV NS4B were found.
Conclusion: Some of the seven pancreatic proteins may be
related with metabolisms of glucose and lipid.
PP-132 Treatment outcome in patients with Hepatitis C:
Signiﬁcance of baseline parameters and viral
dynamics
H. Aziz1, A. Khalid1,2 *, S. Murtaza1, J. Irfan1, A. Raza1.
1Nuclear Oncology and Radiotherapy Institute (NORI),
2National University of Sciences and Technology/Army
Medical College, Pakistan
Background: Hepatitis C constitutes a major public
health issue around the world, especially in developing
countries like Pakistan. The combination therapy with
ribavirin has markedly improved the virologic response
rates in hepatitis C patients. Considerable side effects and
treatment costs make it desirable to identify the patients at
risk of treatment failure. In this study, we investigated the
prognostic signiﬁcance of HCV genotyping, HCV-RNA viral
load and ALT levels in the treatment outcome of patients
suffering with chronic Hepatitis C infection.
Materials & Methods: Three hundred and twenty ﬁve
patients with chronic HCV were enrolled. The mean age was
37.85±10.03. Personal history, serum ALT, pre treatment
HCV RNA levels and genotype were quantiﬁed at the start
of the treatment. Patients were treated with combination
therapy of INF-a2a (three million units thrice a week) plus
ribavirin (1000 1200mg per day) for 24 weeks. HCV RNA
and serum ALT level were quantiﬁed at the end of the
treatment.
Results: Three hundred and eight patients completed
treatment. Sustained virologic response (SVR) to
therapeutic regimen was achieved in 196 (63.3%) of the
patients. 54.5% were women and 45.5% were men. The
SVR rate by genotypes was as follows: Genotype 3a = 66%
(179 of 271), 3b = 50% (2 of 4) genotype 1a = 46.2% (6 of
13 patients), genotype 1b = 44% (4 of 9), genotype 3a+3b =
50% (4 of 8) and genotype 1a+3a = 33% (1 of 3). ALT levels
did not show any predictive signiﬁcance. Best treatment
response was observed in patients with genotype 3, low
viral load <8×105IU/ml and age 40.
Conclusion: It is beneﬁcial to include predictive variables
such as HCV genotype and pretreatment quantiﬁcation of
viral load in the cost-beneﬁt analysis of HCV treatment to
increase the effectiveness in management of hepatitis C
infection.
PP-133 High prevalence of hepatitis C infection among
high risk groups in Kohgiloyeh and Boyerahmad
Province, Southwest of Iran
B. Sarkari1 *, O. Eilami2, A. Khosravani2, M. Akbartabartori3,
M. Tabatabaee2. 1Faculty of Medicine, Shiraz University of
Medical Sciences, Shiraz, Iran, 2Faculty of Medicine, Yasuj
University of Medical Sciences, Yasuj, Iran, 3Faculty of
Health, Yasuj University of Medical Sciences, Yasuj, Iran
Objectives: Detection of HCV-infected people in each
community helps the control and prevention of the
infection. This study aimed to evaluate the prevalence
of HCV infection among high risk groups in Kohgiloyeh and
Boyerahmad province in Southwest of Iran.
Materials and Methods: This study was conducted through
2009 to 2010 in Kohgiloyeh and Boyerahmad province in Iran.
High risk groups for HCV were the subjects of this study.
Blood samples were taken from 2009 individuals at high risk
for HCV including inmates, injecting drug users, health care
workers patients on maintenance hemodialysis, hemophilic
patients and patients with a history of blood transfusion
from Yasuj, Gachsaran, and Dehdasht (three main townships
in the province) and tested by ELISA for anti-HCV antibodies.
Demographic features of participants were recorded using
a questionnaire during sample collecting.
Results: Of 2009 subjects, HCV antibodies were detected
in 172 (8.6%) of subjects. Rate of infection was higher
in males (11.4%) compared to females (3.2%). Rate of
infection in inmates was 11.7% while this rate was 42.4% in
injecting drug users, 4.2% in health care workers, and 6.1%
in thalassemic patients. Signiﬁcant correlation was found
between HCV infection and sex, marital status, history of
imprisonment, drug addiction, level of education and place
of residence.
Conclusion: Results of this study may help to hold back the
spread of HCV infection in this and other similar settings in
the region. Furthermore, ﬁndings of this study may help in
improving the surveillance and prevention of the infection
in the community through management and monitoring of
infected individuals.
PP-134 Screening of proteins binding to hepatitis C
virus NS4B protein from human pancreas cDNA
library
J.Q. Zhang1 *. 1Institue of Infectious Diseases, Beijing Ditan
Hospital, Capital Medical University, China
Aim: To screen proteins from human pancreas cDNA library,
which interact with hepatitis C virus (HCV) NS4B protein.
Methods: The human pancreas cDNA library was ampliﬁed,
puriﬁed and evaluated, and the puriﬁed library plasmids
were transformed into yeast strain Y187. The reconstructed
plasmid pGBKT7-NS4B was transformed into yeast strain
AHl09 and screened on the nutrient deﬁciency medium SD/
-Trp. The transformedAHl09 mated with Y187 that contained
the library plasmids. The diploid yeast cells were plated
on nutrient deﬁciency medium SD/-Trp/-Leu/-His/-Ade and
SD/-Trp/-Leu/-His/-Ade containing X-a-gal for selecting.
The plasmids in diploid yeast cells were extracted and
electrotransformed into E. coli DH5a. The plasmids in DH5a
were extracted, sequenced and blasted.
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Result: The human pancreas cDNA library was constructed
successfully. The reconstructed bait plasmid (pGBKT7-HCV
NS4B) was transformed into yeast cells AHl09 successfully.
Eight proteins interacting with HCV NS4B were found.
Conclusion: Some of the eight pancreatic proteins may be
related with metabolisms of glucose and lipid.
PP-135 The efﬁciency of blood-borne HCV ampliﬁcation
in different three dimensional cell culture
systems in vitro
Y. Qi1, Q.L. Jin1, X.Y. Wen1, J.Q. Niu1. 1Division of liver
diseases, the ﬁrst hospital of Jilin University, Changchun,
China
Background: Immortalized human hepatocytes HuS-E/2
cells cultured in Hollow ﬁber (HF) support the blood-borne
hepatitis C virus (HCVbb) infection in vitro. But several
limits of the HF system stand in the way of its usage
for HCV research. This study is to evaluate the efﬁciency of
different three dimensional (3-D) culture systems for HCVbb
ampliﬁcation in vitro.
Methods: HuS-E/2 cells were cultured in different 3-D cell
culture systems, HF, hydrocell plate (HP) and mebiol gel
(MG). Serum and plasma from hepatitis C patients were used
for infection of the cells. Plasma was pre-treated with Ca2+
containing solution for the infection. Cell proliferation was
monitored with XTT assay. HCV ampliﬁcation in 3-D cultured
cells was measured with real time PCR.
Results: Stable cell proliferation was observed in both
HF and MG system. HCVbb ampliﬁcation in HuS-E/2 cells
which were cultured in HF, HP and MG exhibited the similar
patterns although the titer in cells of different systems is
variational.
Conclusion: All three 3-D systems can support the
proliferation of HCVbb. The selection of the system for
research depends on other factors such as the objective of
the research, culture condition and so on.
PP-136 Antiviral therapy of patients with
decompensated cirrhosis associated with
hepatitis C virus infection
F.P. Ji1 *, H. Deng1. 1Department of Infectious Disease,
the Second Afﬁliated Hospital, College of Medicine, Xi’an
Jiaotong University, China
Patients with hepatitis C virus (HCV)-related decompensated
cirrhosis are associated with a poor prognosis. Although
liver transplantation (LT) offers an effective treatment,
HCV reinfection of the transplanted graft is a critical
and almost inevitable complication with major inﬂuence
on graft- and patient survival. Antiviral therapy of this
patient population is difﬁcult, the use of interferon and
ribavirin might expose these patients to severe treated-
related side effects as a large proportion of them have
pre-existing hematological cytopenias. However, antiviral
treatment in patients with advanced liver cirrhosis is
a potential option for two reasons: ﬁrst, clearing or
suppressing HCV before LT may reduce or eliminate the
risk of recurrent hepatitis C in the transplanted liver and
thereby improve survival; second, clearing HCV in cirrhotic
patient may halt disease progression and avoid the need
for transplantation. Basd on AASLD and ESAL guidelines,
antiviral therapy in this patient population is generally
recommended, but indication, optimal timing, dose and
duration of therapy are not clearly deﬁned. In this article,
the results obtained by antiviral regimens administered to
HCV-related decompensated cirrhosis are discussed.
PP-137 Suppression of HCV replication in hepatocytes
through a selective induction of IRF7
Q.L. Jin1 *, X.Y. Wen1, C. Yang1, J.Q. Niu1. 1Department
of Hepatology, First Hospital, Jilin University, Changchun,
China
Background: A high risk of chronicity is the major concern
of HCV infection and chronic infection often leads to liver
cirrhosis and hepatocellular carcinoma. Although proportion
of patients achieving a sustained virological response has
been increased by the introduction of combination therapy
of pegylated-IFN-alpha and ribavirin, still half of the
patients exhibits no response to the therapy. One of the
mechanisms for the establishment of persistent infection
of HCV is the escape from the host immune system.
To eliminate HCV from the hepatocytes of the patients
without possible cytotoxity due to anover induction of host
immunity, we generated a therapeutic construct, cMR3, by
which type I IFN is selectively induced in HCV infected
cells.
Methods: The cMR3 is composed of the N-terminal part
of the interferon regulatoryfactor 7 (IRF7) possessing a
dominant active function, the sequences speciﬁcally cleaved
by HCV NS3/4A protease and an ER anchor, and exhibits
apotent IFN inducing activity in HCV infected cells. After
cleavage by the HCV protease, the processed cMR3 migrates
into the nucleus and activates various IFN promoters
including IFN-alpha6, IFNbeta, and IFN stimulated response
element.
Results: The speciﬁc activation ofthe IFN promoters was
observed in both HCV replicon cells and JFH1 virus infected
cells upon introduction of the cMR3 but not in cells infected
with JEVor DENV. Expression of viral protein and viral RNA
replication were also impaired by the introduction of cMR3
into the HCV replicon cells.
Conclusion: These results suggest that the selective
expression of type I IFN in the hepatocytes infected with
HCV by the introduction of the cMR3 might be feasibleto
eliminate HCV from the chronic hepatitis C patients without
liver damage.
PP-138 CD44v6 expression in HCV-infected cells and
the correlation with apoptosis resistance
X.Y. Wen1 *, Q.L. Jin1, Y. Qi1, C. Yang1, J.Q. Niu1.
1Department of Hepatology, First Hospital, Jilin University,
Changchun, China
Background: Hepatitis C virus (HCV) infects about 170
million people worldwide and is a major cause of chronic
hepatitis, cirrhosis, and hepatocellular carcinoma (HCC).
Several mechanisms have been proposed for the incidence
of HCC, including apoptosis resistance. CD44, an integral
cell membrane glycoprotein and adhesion molecule, plays
a critical role in a number of important cellular function
including activating anti-apoptosis signal pathway. The aim
of this study were to investigate the expression of CD44v6
in liver cancer tissues and to determine its correlation
with apoptosis resistance via upregulated activity of the
PI3K/AKT pathway.
Methods: We examined the expression of CD44 in liver
cancer tissues in patients with HCV-related HCC compared
with in liver tissues in health controls by Western blot and
the expression of CD44v6 in HCV replicon and JFH1-infected
cells compared with in Huh7 by FACS. Furthermore, we
investigated the apoptosis of CD44 knockdown HCV replicon
and HCV-infected cells treated by ActD compared with that
in negative control cells.
Results: HCV-related HCC liver cancer tissues expressed
signiﬁcantly higher CD44 protein levels than tissues in health
controls. Signiﬁcantly higher CD44v6 were observed in HCV
